Axillary Recurrence After a Negative Sentinel Lymph Node Biopsy (SLNB) for Initial Positive Node Breast Cancer Postneoadjuvant Therapy: Insights From a Systematic Review and Meta‐Analysis
Authors:
- Maha A. AlghamdiMAMaha A. Alghamdi
- Hemali DeshpandeHDHemali Deshpande
- Walid M. Abd El MaksoudWMWalid M. Abd El Maksoud
- Fahad S. Al AmriFAFahad S. Al Amri
- Mohammed A. BawahabMBMohammed A. Bawahab
- Khaled S. AbbasKAKhaled S. Abbas
- Abdullah DalbohADAbdullah Dalboh
- Hassan A. AlzahraniHAHassan A. Alzahrani
- Marei H. AlshandeerMAMarei H. Alshandeer
- Ahmad Jebril M. BosailyABAhmad Jebril M. Bosaily
- Haytham M. FayedHFHaytham M. Fayed
- Ibrahim A. AlghamdiIAIbrahim A. Alghamdi
Open Access
- 1 January 2026
- journal article
- review article
- Published by Wiley in The Breast Journal
- Vol. 2026 (1)
Abstract
Background: Despite the use of sentinel lymph node biopsy (SLNB) to stage the axilla in clinically node‐negative breast cancer patients’ postneoadjuvant therapy, the incidence and clinical significance of axillary recurrence (AR) after a negative SLNB remain under‐explored in the literature. Understanding these factors is essential to improving patient outcomes and guiding future treatment strategies. Methods: We conducted a systematic review and meta‐analysis using PubMed, Scopus, ScienceDirect, and Google Scholar. A random effects model was used to calculate pooled incidence of AR, while heterogeneity was assessed using the I 2 and Q‐statistics. Publication bias was evaluated with a funnel plot and Egger’s test. We performed all analyses using the R meta and metafor packages. Results: A total of 37 studies were included in the qualitative synthesis and meta‐analysis. The pooled analysis of these studies highlights a remarkably low incidence of AR, with an overall proportion of 1% (95% CI: [0.0%, 1.0%]) under a random‐effects model and no significant heterogeneity ( I 2 = 0%, p = 0.95). Egger’s test for publication bias was conducted to assess the presence of funnel plot asymmetry in the meta‐analysis, indicating no significant evidence of publication bias ( z ‐value = 0.6074, p ‐value = 0.5436). Conclusion: The meta‐analysis demonstrated a remarkably low incidence of AR after a negative SLNB in initially node‐positive breast cancer patients postneoadjuvant therapy. These findings suggest that such recurrences are rare, supporting the reliability of SLNB in accurately staging the axilla. This highlights its importance in clinical decision‐making for treatment strategies.Keywords
Funding Information
- King Khalid University (RGP2/533/46)
This publication has 55 references indexed in Scilit:
- Clinical outcome of patients with lymph node‐negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistryCancer, 2005
- Treatment of Axillary Lymph Node-Negative, Estrogen Receptor-Negative Breast Cancer: Updated Findings From National Surgical Adjuvant Breast and Bowel Project Clinical TrialsJNCI: Journal of the National Cancer Institute, 2004
- The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node DissectionAnnals of Surgery, 2004
- Micrometastasis in the Sentinel Lymph Node of Breast Cancer Does Not Mandate Completion Axillary DissectionAnnals of Surgery, 2004
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerNew England Journal of Medicine, 2003
- Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary DissectionAnnals of Surgical Oncology, 2003
- Axillary Dissection Is Not Required for All Patients With Breast Cancer and Positive Sentinel NodesArchives of Surgery, 2003
- Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by IrradiationNew England Journal of Medicine, 2002
- Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?The American Journal of Surgery, 2001
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994